| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $794K | -90.4% |
| Cost of Revenue | $6.4M | +28.9% |
| Gross Profit | $3.0M | -9.7% |
| R&D Expense | $597K | +39.2% |
| SG&A Expense | $4.8M | +42.1% |
| Operating Income | -$5.7M | -45.5% |
| Pre-tax Income | -$5.9M | -46.5% |
| Net Income | -$5.9M | -46.5% |
| EPS (Basic) | -$1.87 | +57.4% |
| EPS (Diluted) | -$1.87 | +57.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | -52.8% |
| Accounts Receivable | $1.2M | +336.7% |
| Inventory | $3.0M | +8.5% |
| Current Assets | $7.7M | -14.7% |
| Total Assets | $10.2M | +1.4% |
| Current Liabilities | $4.1M | +37.9% |
| Long-term Debt | $831K | +469.2% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -66.3% |
| Capital Expenditures | $16K | +128.6% |
| Investing Cash Flow | -$196K | -469.8% |
| Financing Cash Flow | $3.0M | -46.5% |
| Free Cash Flow | -$5.2M | -66.4% |
| $5.0M |
| +60.2% |
| Stockholders' Equity | $5.2M | -25.4% |